{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:11:17Z","timestamp":1789420277618,"version":"build-2803163510"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T00:00:00Z","timestamp":1510531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["109523"],"award-info":[{"award-number":["109523"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nothing is forever e.V.","award":["604242"],"award-info":[{"award-number":["604242"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0187700","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T18:37:39Z","timestamp":1510598259000},"page":"e0187700","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro"],"prefix":"10.1371","volume":"12","author":[{"given":"Susan","family":"Fischer-Huchzermeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dombrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Stahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Streubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Felix","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3045-2222","authenticated-orcid":true,"given":"Anja","family":"Harder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,11,13]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","article-title":"Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases","volume":"57","author":"BS Ducatman","year":"1986","journal-title":"Cancer"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF02303627","article-title":"Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience","volume":"2","author":"JN Vauthey","year":"1995","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","article-title":"The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2","volume":"278","author":"DH Gutmann","year":"1997","journal-title":"JAMA"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"DG Evans","year":"2002","journal-title":"J Med Genet"},{"issue":"14","key":"ref5","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/glia.20776","article-title":"How does the Schwann cell lineage form tumors in NF1?","volume":"56","author":"SL Carroll","year":"2008","journal-title":"Glia"},{"issue":"20","key":"ref6","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/hmg\/9.20.3055","article-title":"Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations","volume":"9","author":"E Serra","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/hmg\/9.7.1059","article-title":"Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1","volume":"9","author":"JL Rutkowski","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<283::AID-GCC15>3.0.CO;2-K","article-title":"Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma","volume":"24","author":"L Kluwe","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/humu.20389","article-title":"Comprehensive NF1 screening on cultured Schwann cells from neurofibromas","volume":"27","author":"O Maertens","year":"2006","journal-title":"Hum Mutat"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/humu.10272","article-title":"Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: toward a theory of genetic modifiers","volume":"22","author":"V Wiest","year":"2003","journal-title":"Hum Mutat"},{"key":"ref11","article-title":"Somatic neurofibromatosis type 1 (NF1) inactivation events in cutaneous neurofibromas of a single NF1 patient","author":"D Emmerich","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2741\/3727","article-title":"Genetic basis of tumorigenesis in NF1 malignant peripheral nerve sheath tumors","volume":"16","author":"M Upadhyaya","year":"2011","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0002-9440(10)65504-6","article-title":"Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas","volume":"155","author":"HP Kourea","year":"1999","journal-title":"Am J Pathol"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0002-9440(10)65507-1","article-title":"Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A\/p16 inactivation","volume":"155","author":"GP Nielsen","year":"1999","journal-title":"Am J Pathol"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/gcc.2870100405","article-title":"TP53 mutations are frequent in malignant NF1 tumors","volume":"10","author":"E Legius","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"issue":"14","key":"ref16","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1073\/pnas.87.14.5435","article-title":"Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis","volume":"87","author":"AG Menon","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"VC Williams","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3171\/foc.2007.22.6.14","article-title":"Surgical management of malignant peripheral nerve sheath tumors","volume":"22","author":"J Gachiani","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00401-007-0265-y","article-title":"Joint Meeting of the German Society of Neuropathology and Neuroanatomy (DGNN) and the Polish Association of Neuropathologists with International Participation in Conjunction with the 52nd Annual Meeting of the German Society of Neuropathology and Neuroanatomy (DGNN). Expression of the cellular retinoic acid binding protein II (CRABPII) is different in Neurofibromatosis type I associated nerve sheath tumors\u2014is there a link to tumor growth and biology?","volume":"114","author":"A. Harder","year":"2007","journal-title":"Acta Neuropathologica"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3892\/or.2014.3379","article-title":"TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions","volume":"32","author":"GH Park","year":"2014","journal-title":"Oncol Rep"},{"issue":"7","key":"ref21","first-page":"1623","article-title":"The cellular retinoic acid binding protein 2 (CRABP2) promotes survival of malignant peripheral nerve sheath tumor (MPNST) cells","volume":"187","author":"S Fischer-Huchzermeyer","year":"2017","journal-title":"AmJPathol"},{"key":"ref22","unstructured":"Fischer S., Dombrowski A., Wilke G., Mautner V.F., Friedrich R.E., A. H. Phenotypes of NF1 associated Peripheral Nerve Sheath Tumors are associated with modified Retinoic acid signaling mediated by differential CRABPII expression. 57. Jahrestagung der Deutschen Gesellschaft f\u00fcr Neuropathologie und Neuroanatomie (DGNN). German Medical Science. 2012:Doc12dgnnPP3."},{"key":"ref23","unstructured":"Fischer-Huchzermeyer S. The role of retinoic acid and CRABP2 in NF1-associated peripheral nerve sheath tumours. Thesis, University of Muenster, Germany. 2014."},{"key":"ref24","unstructured":"Dombrowski A., Guse K., Holtkamp N., Kluwe L., Heppner F.L., Friedrich R.E., et al. Antiproliferative effects of all-trans retinoic acid (ATRA) on neurofibroma cultures and MPNST cell lines. The Childrens Tumor Foundation Conference, Baltimore. 2010;Abstract book:27."},{"key":"ref25","unstructured":"Fischer S., Dombrowski A., Wilke G., Mautner V.F., Friedrich R.E., A. H. Role of Retinoic Acid Signalling in subtypes of NF1 associated Peripheral Nerve Sheath Tumors. The Children\u2019s Tumor Foundation Conference, New Orleans 2012;Abstract book:35."},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrn2212","article-title":"Retinoic acid in the development, regeneration and maintenance of the nervous system","volume":"8","author":"M Maden","year":"2007","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cell.2007.02.050","article-title":"Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors","volume":"129","author":"TT Schug","year":"2007","journal-title":"Cell"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg2340","article-title":"Retinoic acid in development: towards an integrated view","volume":"9","author":"K Niederreither","year":"2008","journal-title":"Nat Rev Genet"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1056\/NEJM199307153290307","article-title":"Acute promyelocytic leukemia","volume":"329","author":"RP Warrell Jr.","year":"1993","journal-title":"N Engl J Med"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00277-016-2810-z","article-title":"All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07\u201304 study","volume":"95","author":"RF Schlenk","year":"2016","journal-title":"Ann Hematol"},{"issue":"27","key":"ref31","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1038\/sj.onc.1208661","article-title":"Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells","volume":"24","author":"M Lu","year":"2005","journal-title":"Oncogene"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/CJI.0b013e31805449a8","article-title":"Phase 1\/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma","volume":"30","author":"SA Boorjian","year":"2007","journal-title":"J Immunother"},{"issue":"18","key":"ref33","doi-asserted-by":"crossref","first-page":"8193","DOI":"10.1158\/0008-5472.CAN-05-1177","article-title":"Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling","volume":"65","author":"LJ Donato","year":"2005","journal-title":"Cancer Res"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bmc.2013.11.025","article-title":"Retinoic acid signaling pathways in development and diseases","volume":"22","author":"BC Das","year":"2014","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jcp.10045","article-title":"Inhibition of Caco-2 cell proliferation by all-trans retinoic acid: role of insulin-like growth factor binding protein-6","volume":"190","author":"EJ Kim","year":"2002","journal-title":"J Cell Physiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jprot.2013.11.010","article-title":"Proteome analysis of the effects of all-trans retinoic acid on human germ cell tumor cell lines","volume":"96","author":"F Honecker","year":"2014","journal-title":"J Proteomics"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1200\/JCO.2007.13.8925","article-title":"Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children&apos;s oncology group study","volume":"27","author":"KK Matthay","year":"2009","journal-title":"J Clin Oncol"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood.V94.4.1192","article-title":"A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group","volume":"94","author":"P Fenaux","year":"1999","journal-title":"Blood"},{"issue":"18","key":"ref39","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1200\/JCO.2005.07.114","article-title":"Randomized phase II\/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951)","volume":"23","author":"N Aass","year":"2005","journal-title":"J Clin Oncol"},{"issue":"17","key":"ref40","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1158\/0008-5472.CAN-05-2726","article-title":"Sequential valproic acid\/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia","volume":"66","author":"G Cimino","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cell.2010.06.004","article-title":"NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome","volume":"142","author":"M Holzel","year":"2010","journal-title":"Cell"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ccr.2009.02.023","article-title":"ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome","volume":"15","author":"S Huang","year":"2009","journal-title":"Cancer Cell"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2004.01.006","article-title":"Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients","volume":"16","author":"S Frahm","year":"2004","journal-title":"Neurobiol Dis"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/carcin\/bgi273","article-title":"Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity","volume":"27","author":"N Holtkamp","year":"2006","journal-title":"Carcinogenesis"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"e21099","DOI":"10.1371\/journal.pone.0021099","article-title":"Cancer stem cell-like cells derived from malignant peripheral nerve sheath tumors","volume":"6","author":"M Spyra","journal-title":"PLoS One"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S1740925X04000274","article-title":"Transcriptional profiling in an MPNST-derived cell line and normal human Schwann cells","volume":"1","author":"PR Lee","year":"2004","journal-title":"Neuron Glia Biol"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/1097-4547(20000901)61:5<524::AID-JNR7>3.0.CO;2-Z","article-title":"Long-term culture and characterization of human neurofibroma-derived Schwann cells","volume":"61","author":"T Rosenbaum","year":"2000","journal-title":"J Neurosci Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-61779-108-6_6","article-title":"The xCELLigence system for real-time and label-free monitoring of cell viability","volume":"740","author":"N Ke","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10616-014-9692-5","article-title":"Dynamic assessment of cell viability, proliferation and migration using real time cell analyzer system (RTCA)","volume":"67","author":"M Roshan Moniri","year":"2014","journal-title":"Cytotechnology"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"OH Lowry","year":"1951","journal-title":"J Biol Chem"},{"issue":"5259","key":"ref52","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"UK Laemmli","year":"1970","journal-title":"Nature"},{"issue":"11","key":"ref53","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1194\/jlr.R100015-JLR200","article-title":"Gene expression regulation by retinoic acid","volume":"43","author":"JE Balmer","year":"2002","journal-title":"J Lipid Res"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors","volume":"123","author":"WJ Jessen","year":"2012","journal-title":"J Clin Invest"},{"issue":"13","key":"ref55","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1016\/j.bmc.2006.02.041","article-title":"Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases","volume":"14","author":"VC Njar","year":"2006","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molonc.2011.11.004","article-title":"CRABP-II methylation: A critical determinant of retinoic acid resistance of medulloblastoma cells","volume":"6","author":"YS Fu","year":"2012","journal-title":"Mol Oncol"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004280050271","article-title":"Characterization and chemosensitivity of two human malignant peripheral nerve sheath tumour cell lines derived from a patient with neurofibromatosis type 1","volume":"433","author":"S Imaizumi","year":"1998","journal-title":"Virchows Arch"},{"issue":"Pt 4","key":"ref58","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1242\/jcs.119701","article-title":"RARgamma is essential for retinoic acid induced chromatin remodeling and transcriptional activation in embryonic stem cells","volume":"126","author":"V Kashyap","year":"2013","journal-title":"J Cell Sci"},{"issue":"7","key":"ref59","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood.V82.7.2175.2175","article-title":"Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells","volume":"82","author":"L Delva","year":"1993","journal-title":"Blood"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathol-011110-130303","article-title":"Retinoids, retinoic acid receptors, and cancer","volume":"6","author":"XH Tang","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"ref61","article-title":"Epigenetically mediated down-regulation of the differentiation-promoting chaperon protein CRABP2 in astrocytic gliomas","author":"B Campos","year":"2012","journal-title":"Int J Cancer"},{"issue":"20","key":"ref62","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1016\/j.yexcr.2008.09.029","article-title":"Regulation of CRABP-II expression by MycN in Wilms tumor","volume":"314","author":"A Gupta","year":"2008","journal-title":"Exp Cell Res"},{"issue":"1","key":"ref63","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1158\/1078-0432.CCR-11-2165","article-title":"Molecular determinants of retinoic acid sensitivity in pancreatic cancer","volume":"18","author":"S Gupta","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0092-8674(92)90267-G","article-title":"All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs","volume":"71","author":"B Durand","year":"1992","journal-title":"Cell"},{"issue":"34","key":"ref65","doi-asserted-by":"crossref","first-page":"23695","DOI":"10.1074\/jbc.274.34.23695","article-title":"Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid","volume":"274","author":"D Dong","year":"1999","journal-title":"J Biol Chem"},{"issue":"1A","key":"ref66","first-page":"217","article-title":"Transcriptional regulation of retinoic acid responsive genes by cellular retinoic acid binding protein-II modulates RA mediated tumor cell proliferation and invasion","volume":"18","author":"HP Vo","year":"1998","journal-title":"Anticancer Res"},{"issue":"5","key":"ref67","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.ajpath.2011.01.051","article-title":"Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas","volume":"178","author":"B Campos","year":"2011","journal-title":"Am J Pathol"},{"issue":"21","key":"ref68","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1073\/pnas.0709981105","article-title":"Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta\/delta to RAR","volume":"105","author":"TT Schug","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref69","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ajpath.2010.11.075","article-title":"Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy","volume":"178","author":"RZ Liu","year":"2011","journal-title":"Am J Pathol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0187700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T05:20:39Z","timestamp":1659849639000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0187700"}},"subtitle":[],"editor":[{"given":"Michael","family":"Schubert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,13]]},"references-count":69,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0187700","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,13]]}}}